Gilenya fails in progressive MS / Tysabri injections

A round up of presentations from AAN includes a study that found fingolimod (Gilenya) didn't slow progressive MS and research that shows injections of natalizumab (Tysabri) were as effective as infusions. Presented at the American Academy of Neurology (AAN) meeting. MedPage Today Fingolimod (Gilenya) - A to Z of MS Natalizumab (Tysabri) - A to Z of MS
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news